Guhan Pharmaceutical Group Co., Ltd. (SHE:000590)

China flag China · Delayed Price · Currency is CNY
11.16
+0.06 (0.54%)
Apr 30, 2026, 3:04 PM CST
Market Cap2.67B +25.5%
Revenue (ttm)344.12M +3.9%
Net Income-41.07M
EPS-0.17
Shares Out239.47M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume3,746,672
Average Volume4,469,136
Open10.77
Previous Close11.10
Day's Range10.77 - 11.27
52-Week Range8.64 - 15.25
Beta0.35
RSI45.44
Earnings DateApr 30, 2026

About SHE:000590

Guhan Pharmaceutical Group Co., Ltd., together with its subsidiaries, manufactures and sells traditional Chinese medicines, chemical drugs, and health food under the Guhan brand in China. It operates through the Pharmaceutical and Health Product Manufacturing and Sales Business, Active Pharmaceutical Ingredient (API) Manufacturing and Sales Business, and Other Business segments. The company offers prescription and over-the-counter drugs, such as tonics, cardiovascular drugs, children's nutritional supplements, cold and flu remedies, and heat-cl... [Read more]

Sector Healthcare
Founded 1956
Employees 1,064
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 000590
Full Company Profile

Financial Performance

In 2025, SHE:000590's revenue was 337.67 million, a decrease of -1.61% compared to the previous year's 343.21 million. Losses were -50.52 million, -59.74% less than in 2024.

Financial Statements